NM_001030005.3:c.31G>A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001030005.3(CPLX3):​c.31G>A​(p.Gly11Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000844 in 1,610,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000088 ( 0 hom. )

Consequence

CPLX3
NM_001030005.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.72
Variant links:
Genes affected
CPLX3 (HGNC:27652): (complexin 3) Predicted to enable SNARE binding activity. Predicted to be involved in regulation of neurotransmitter secretion and synaptic vesicle exocytosis. Predicted to be located in plasma membrane and synapse. Predicted to be part of SNARE complex. Predicted to be active in photoreceptor ribbon synapse and terminal bouton. Predicted to be anchored component of presynaptic active zone membrane and anchored component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10791838).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPLX3NM_001030005.3 linkc.31G>A p.Gly11Ser missense_variant Exon 1 of 3 ENST00000395018.6 NP_001025176.1 Q8WVH0A0A384N6F4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPLX3ENST00000395018.6 linkc.31G>A p.Gly11Ser missense_variant Exon 1 of 3 1 NM_001030005.3 ENSP00000378464.4 Q8WVH0
ENSG00000261606ENST00000488000.6 linkn.3240G>A non_coding_transcript_exon_variant Exon 12 of 14 2
ENSG00000261606ENST00000564823.1 linkn.3469G>A non_coding_transcript_exon_variant Exon 4 of 6 2

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000170
AC:
42
AN:
246974
Hom.:
0
AF XY:
0.000134
AC XY:
18
AN XY:
133966
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000233
Gnomad NFE exome
AF:
0.000314
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.0000877
AC:
128
AN:
1458802
Hom.:
0
Cov.:
31
AF XY:
0.0000923
AC XY:
67
AN XY:
725720
show subpopulations
Gnomad4 AFR exome
AF:
0.0000302
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000282
Gnomad4 NFE exome
AF:
0.0000891
Gnomad4 OTH exome
AF:
0.000216
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152196
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000283
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.000288
AC:
35

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 18, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.31G>A (p.G11S) alteration is located in exon 1 (coding exon 1) of the CPLX3 gene. This alteration results from a G to A substitution at nucleotide position 31, causing the glycine (G) at amino acid position 11 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.044
Eigen_PC
Benign
0.048
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.6
L
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-0.61
N
REVEL
Benign
0.082
Sift
Benign
0.28
T
Sift4G
Benign
0.41
T
Polyphen
0.17
B
Vest4
0.17
MutPred
0.39
Gain of phosphorylation at G11 (P = 0.0789);
MVP
0.48
MPC
0.27
ClinPred
0.063
T
GERP RS
3.4
Varity_R
0.15
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750321038; hg19: chr15-75119075; API